Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?
preprint
OA: closed
Abstract
The vascular endothelial growth factor (VEGF) family includes key mediators of vasculogenesis and angiogenesis. VEGFs are secreted by various cells of epithelial and mesenchymal origin and by some immune cells in response to physiological and pathological stimuli. In addition, immune cells express VEGF receptors and/or coreceptors and can respond to VEGFs in an autocrine or paracrine manner. This immunological role of VEGFs has opened the possibility to use the VEGF inhibitors already developed to inhibit tumor angiogenesis also in combination approaches with different immunotherapies to enhance the action of effector T lymphocytes against tumor cells. This review aims at analyzing the current knowledge on the crosstalk between VEGFs and the immune system and at highlighting those aspects that still need to be further investigated.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00